Position in INDV
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$11,391,412
New position
Shares Held
373,734
first reported quarter
Ownership
0.307%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 29.03134314780031.ToString("F0")%
Shared 0.ToString("F0")%
None 70.9686568521997.ToString("F0")%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026LSV ASSET MANAGEMENT holds $422,940,937 across 17 Drug Manufacturers - Specialty & Generic names. INDV ranks #6 (2.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
398,665 | $236,400,371 | |
| 2 | VTRS |
Viatris Inc
|
7,890,441 | $106,599,857 | |
| 3 | AMPH |
Amphastar Pharmaceuticals, Inc.
|
651,714 | $12,767,077 | |
| 4 | PCRX |
Pacira BioSciences, Inc.
|
517,100 | $11,686,460 | |
| 5 | COLL |
Collegium Pharmaceutical, Inc
|
345,200 | $11,415,764 | |
| 6 | INDV |
Indivior Pharmaceuticals, Inc.
This page
|
373,734 | $11,391,412 | |
| 7 | PAHC |
Phibro Animal Health Corp
|
165,300 | $9,142,743 | |
| 8 | EBS |
Emergent BioSolutions Inc.
|
896,700 | $7,442,610 |
All Filings in INDV
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $11,391,412 | 373,734 | Shares | Sole | 2026-05-11 | |
| No filing history on record for this holder in this stock. | ||||||